Bristol Myers Squibb Q3 Profit Falls to $2.16 Billion, Revenue Rises 6.9% to $13.07 Billion

Bristol Myers Squibb Co. (BMY) reported a third-quarter profit of $2.162 billion, or $1.05 per share, down from $2.201 billion, or $1.08 per share, in the same period last year. Excluding items, the company posted adjusted earnings of $2.767 billion, or $1.35 per share. Revenue for the quarter rose 6.9% to $13.069 billion from $12.222 billion a year earlier. The drugmaker guided full-year EPS to a range of $6.35 to $6.55 and full-year revenue to $49.75 billion to $50.25 billion.